Structures by: An L. K.
Total: 7
C27H32N2O4
C27H32N2O4
Journal of medicinal chemistry (2018) 61, 22 9908-9930
a=9.41991(12)Å b=10.11440(12)Å c=23.7285(4)Å
α=90° β=91.6653(13)° γ=90°
C19H20O4
C19H20O4
Organic letters (2013) 15, 6 1162-1165
a=9.8118(3)Å b=8.1212(2)Å c=10.1150(3)Å
α=90.00° β=104.002(3)° γ=90.00°
C29H48O3,CH4O
C29H48O3,CH4O
Organic & biomolecular chemistry (2020) 18, 27 5130-5136
a=6.61847(5)Å b=9.54000(6)Å c=44.1844(3)Å
α=90° β=90° γ=90°
Ethyl 3-methyl-5-nitro-1H-imidazole-2-carboxylate
C7H9N3O4
Acta Crystallographica Section E (2004) 60, 6 o994-o995
a=8.9400(10)Å b=6.7680(10)Å c=15.028(2)Å
α=90° β=90° γ=90°
6,6,7,7-Tetrachloro-5,6,7,8-tetrahydroquinoline-5,8-dione
C9H3Cl4NO2
Acta Crystallographica Section E (2007) 63, 3 o1365-o1366
a=7.6115(4)Å b=10.3015(6)Å c=14.1723(8)Å
α=90.00° β=90.00° γ=90.00°
5,6,7-Trichloro-2-methoxy-8-hydroxyquinoline
C10H6Cl3NO2
Acta Crystallographica Section E (2011) 67, 5 o1108
a=10.0782(3)Å b=4.99790(10)Å c=21.5827(6)Å
α=90.00° β=99.287(2)° γ=90.00°
Ethyl 9-fluoro-5,12-dioxo-5,12-dihydroindolizino[2,3-<i>g</i>]quinoline-6-carboxylate
C18H11FN2O4
Acta Crystallographica Section E (2012) 68, 8 o2548
a=6.85562(10)Å b=12.12898(16)Å c=17.0304(2)Å
α=90.00° β=94.2306(13)° γ=90.00°